Pet Food Ingredients Market Size & Share 2026-2035

Pet Food Ingredients Market Size

The global pet food ingredients market was valued at USD 37.8 billion in 2025 and is projected to reach USD 64.5 billion by 2035, expanding at a 5.5% CAGR.

This market measures the value of raw materials, additives, and nutritional components procured for commercial pet food, homemade formulations, and treats. It excludes the retail value of finished pet food, packaging, manufacturing equipment, distribution margins, and veterinary pharmaceuticals. In 2025, animal-derived ingredients represented USD 16.908 billion, or 44.8% of global demand, while plant-derived inputs accounted for USD 11.620 billion and additives for USD 7.639 billion. Novel and functional ingredients remain comparatively small at USD 1.601 billion, but their 7.23% projected CAGR makes them the principal source of category mix improvement through 2035.

North America leads demand at USD 13.886 billion in 2025, followed by Europe at USD 10.487 billion and Asia Pacific at USD 9.150 billion. Mature regions remain central to premium-protein, palatability, and functional-additive demand, whereas Latin America and the Middle East & Africa are expected to post the fastest regional growth rates, at 6.06% and 6.40%, respectively. In the United States, pet food manufacturers purchased USD 13.2 billion in farm products in 2024 to support 9.8 million tons of output across 518 FDA-registered facilities; marine ingredient procurement value rose 95% between 2019 and 2024, compared with 34% growth for meat and poultry inputs ^{[1]Institute for Feed Education and Research - Pet Food Report 2025, March 2025 - ifeeder.org}.

Regional expansion follows a different mechanism. North America and Europe sustain demand through reformulation, traceability, and premium formats, while Latin America, Asia Pacific, and the Middle East & Africa add volume as commercial feeding becomes more accessible. Suppliers therefore face two distinct operating models: preserve margin through differentiated technical solutions in mature markets, while building compliant, reliable distribution and local formulation support in earlier-stage markets.

Key Drivers

Pet humanization is raising the technical specification of mainstream formulas. ADM's 2025 consumer research found that 91% of pet owners consider pets important family members, while 78% expressed interest in products that may support longer pet lifespans ^{[2]Archer-Daniels-Midland Company - ADM Pet Nutrition 2025 Insights Report: An Inside Look at the Future of Pet Nutrition, 2025 - adm.com}. This changes procurement behavior: manufacturers need more than baseline nutritional adequacy and increasingly seek named proteins, digestibility support, omega-3 sources, and life-stage-specific nutrient systems. APPA reported that 95 million U.S. households owned at least one pet in 2025, preserving a substantial domestic base for this reformulation cycle .

Premiumization has a measurable effect on input selection. U.S. pet food producers increased marine ingredient procurement value by 95% from 2019 to 2024, materially outpacing growth in meat and poultry procurement value . Marine proteins and oils can serve protein, palatability, and omega-3 positioning simultaneously, allowing suppliers to participate in a higher-value formulation layer. Their supply constraints also make traceability, quality consistency, and secure sourcing more commercially important than simple volume availability.

Functional nutrition is increasing additive intensity. Consumer interest in digestion, immunity, healthy aging, skin and coat, and mobility is moving vitamins, minerals, probiotics, prebiotics, enzymes, and bioactive proteins from optional premium features toward repeatable formulation platforms. ADM found that 53% of U.S. pet owners prioritize digestive health, while demand for health-oriented formats spans multiple geographies and pet types . This supports the additives segment's 5.90% forecast CAGR, above the 5.5% market average.

The trend favors suppliers that can substantiate efficacy and provide application support. Hydrolyzed proteins, palatants, liquid coatings, and targeted premixes have commercial value because their performance is assessed in finished products through taste acceptance, manufacturability, nutrient delivery, and claim credibility. The relevant competitive unit is therefore increasingly a validated formulation solution rather than an isolated commodity ingredient.

Commercial feeding adoption broadens the addressable base in developing regions. The largest incremental opportunities arise where urbanization, rising household income, and organized retail make commercially formulated food more accessible. This supports above-average market growth in Asia Pacific, Latin America, and the Middle East & Africa. Export activity also indicates increasing cross-border commercial food flows: Latin America was the third-largest market for U.S. dog and cat food exports in 2024, with imports of USD 162 million, up 11% from 2023 ^{[3]U.S. Department of Agriculture Foreign Agricultural Service - Brazil: Paw-sitive Outlook for the Pet Food Industry in Brazil - fas.usda.gov}.

Key Restraints

Raw-material volatility complicates formulation economics. Protein meals, fats, oils, pulses, and specialty additives are exposed to agricultural cycles, climate events, trade restrictions, and logistics disruption. Pea protein demonstrates the risk: anti-dumping measures affecting Chinese supply and European crop shortfalls narrowed the spread between food-grade and pet-food-grade pea protein from about EUR 400 per metric ton to EUR 200 per metric ton . When the relative cost advantage of pet-grade material contracts, manufacturers must either absorb cost, reformulate, or pass price increases through to consumers.

Marine oils present a more structural supply challenge. Pet food demand for fish oil is substantial, while alternative algal-oil production remains limited relative to potential replacement needs. This reduces the feasibility of rapid substitution and places a premium on multi-source procurement, dose optimization, and differentiated oil systems. Cost pressure is especially consequential in value-tier food, where ingredient inflation cannot always be recovered through retail pricing without affecting volumes.

Approval requirements lengthen the commercialization path for novel inputs. The expiration of the AAFCO-FDA Memorandum of Understanding on October 1, 2024 changed the operating environment for U.S. ingredient innovators. FDA Guidance for Industry #293 sets enforcement policy for certain AAFCO-defined ingredients, while Guidance for Industry #294 establishes the Animal Food Ingredient Consultation process . AAFCO subsequently introduced its Kansas State University-administered review pathway, adding another route for scientific review .

The direction of travel is constructive, but the transition raises execution requirements. Suppliers must plan for data generation, species-specific scope, regulatory documentation, and timing differences across the United States, Europe, China, and other markets. Novel proteins and functional additives can command premium pricing, yet that opportunity is moderated when approvals, label treatment, and accepted use conditions are not aligned across target geographies.

Regulation further separates technically capable suppliers from simple ingredient traders. Companies able to pair safety documentation, application know-how, and regional regulatory support can shorten customers' commercialization cycles. The most attractive specialty categories may therefore grow quickly, but their growth will be captured unevenly by suppliers that can convert scientific and regulatory readiness into approved, scalable formulations.

Pet Food Ingredients Market Segment Analysis

By Ingredient Type

Animal-derived ingredients are expected to remain the market's largest category, increasing from USD 14.474 billion in 2022 to USD 28.387 billion by 2035 at a 5.32% CAGR. Meat products, fish products, and animal fats provide the protein, energy density, and palatability foundation of conventional formulations. Marine ingredients hold particular strategic value because they combine premium provenance with omega-3 functionality; in the United States, they generated USD 3.5 billion of annual procurement value in 2024 despite materially lower tonnage than meat and poultry inputs . Finite marine resources, however, expose the category to availability and price risk.

Plant-derived ingredients are projected to rise from USD 9.971 billion in 2022 to USD 19.355 billion by 2035. Cereals and grains remain the volume base for many dry formulas, while oilseeds and pulses increasingly provide protein and fiber functionality. Their primary advantage is formulation versatility, but their economics are sensitive to harvest conditions, trade policy, and competition from food markets. The narrowing pea-protein price differential illustrates why plant proteins cannot be treated as uniformly low-cost substitutes for animal inputs ^{[4]Expana Markets - Plant-Based Pet Food Ingredient Prices on the Rise - expanamarkets.com}.

Additives are forecast to reach USD 13.549 billion by 2035, supported by vitamins and minerals, enzymes, probiotics and prebiotics, flavors and colorants, and preservatives. Their 5.90% CAGR reflects the move toward formulas with defined digestive, immunity, palatability, and life-stage roles. Natural preservation systems are also gaining importance. Commission Implementing Regulation (EU) 2024/1068 authorized liquid rosemary extract as an antioxidant additive for cats and dogs, expanding available natural antioxidant options in Europe ^{[5]EUR-Lex - Commission Implementing Regulation (EU) 2024/1068 of 9 April 2024 authorising liquid rosemary extract as antioxidant for cats and dogs - eur-lex.europa.eu}.

The others category, comprising novel proteins and functional ingredients, is projected to grow from USD 1.287 billion in 2022 to USD 3.226 billion by 2035. Insect proteins, algae-derived materials, omega-3 concentrates, and other specialized inputs offer a route to differentiated nutrition and sourcing narratives. The EU's January 2025 authorization of UV-treated yellow mealworm powder adds to the regulatory foundation for alternative protein development, although authorization, consumer acceptance, cost, and production scale remain limiting factors .

By Pet Type

Dogs account for the largest ingredient demand pool, rising from USD 17.594 billion in 2022 to USD 34.194 billion by 2035. Their scale reflects broad ownership and the breadth of dog-food formats, including life-stage diets, breed-specific formulas, therapeutic products, raw formats, and treats. The category's 5.24% CAGR is below the market average because mature dog-food markets increasingly depend on premiumization rather than new ownership.

Cats represent the second-largest segment, expanding from USD 11.579 billion in 2022 to USD 22.581 billion by 2035. Cat formulations tend to require higher animal-protein intensity and species-specific amino acid management, creating sustained demand for animal-derived proteins, palatability systems, taurine-containing premixes, and wet-format inputs. APPA reported 53 million U.S. cat-owning households in 2025, up 5% year over year .

Birds, fish, and other pets remain smaller in absolute value but grow more rapidly, at forecast CAGRs of 7.33%, 7.56%, and 7.71%, respectively. These segments require more specialized ingredient systems, including seed and oilseed blends for birds, aquatic nutrition inputs for fish, and tailored premixes for smaller companion species. Their growth favors suppliers capable of serving fragmented demand without relying on a single high-volume formulation platform.

By Form

Dry ingredients remain dominant, increasing from USD 19.942 billion in 2022 to USD 38.710 billion by 2035. Grain and legume flours, protein meals, dry premixes, and spray-dried palatants support the cost efficiency and shelf stability of dry kibble. The segment's 5.23% CAGR reflects its large installed base and continued relevance as an accessible entry point for commercial pet food in developing markets.

Wet ingredients are projected to increase from USD 8.685 billion to USD 18.065 billion by 2035. Broths, fresh and frozen meat portions, gels, and texture-specific proteins are more central to wet, fresh, refrigerated, and freeze-dried products. U.S. pet food producers procured 184,737 metric tons of broth valued at USD 554 million in 2024, underscoring the scale of ingredients that support moisture-rich formats .

Liquid ingredients are forecast to post the strongest growth within form segmentation, at 6.19%. Liquid oils, palatant coatings, vitamin preparations, enzymes, and prebiotic systems are valuable where post-extrusion application, nutrient dispersion, or sensory performance is important. Their growth reflects both higher functional inclusion and the expanding role of coatings and toppers in premium product architecture.

By Source

Conventional inputs remain the principal sourcing route, rising from USD 28.948 billion in 2022 to USD 57.420 billion by 2035. The segment's 5.41% CAGR reflects the continued importance of standard animal and plant ingredients in global-scale pet food manufacturing. Conventional sourcing will retain its large share because supply chains, certification systems, and formulation costs are better suited to high-volume production.

Organic ingredients are projected to grow from USD 3.217 billion to USD 7.097 billion, at a 6.26% CAGR. Organic sourcing supports transparency-led brand propositions, but it requires segregated procurement, certification management, and reliable availability of certified agricultural inputs. The segment's growth is therefore strongest where premium pricing can absorb the higher ingredient, audit, and supply-chain costs.

By Application

Commercial pet food manufacturing is forecast to rise from USD 24.445 billion in 2022 to USD 48.388 billion by 2035. Its 75.8% share of 2025 demand reflects large-scale manufacturers' purchasing power, formulation capability, and capacity to adopt specialized ingredients at scale. The U.S. production base alone includes 518 FDA-registered facilities, reinforcing the importance of industrial procurement systems to ingredient demand .

Homemade pet food is projected to grow at 6.46%, from USD 2.573 billion in 2022 to USD 5.807 billion by 2035. Demand is linked to owners seeking direct control over ingredient selection and freshness, but ingredient purchasing follows different channels than industrial supply, including specialty retail, e-commerce, and veterinary-adjacent outlets.

Treats and snacks increase from USD 4.503 billion to USD 8.387 billion by 2035. Although forecast growth is lower than in other applications, treats remain an important testing ground for functional claims, palatability technologies, dental-support ingredients, and premium proteins. The others category, including therapeutic and specialized nutritional products, is forecast to expand fastest at 8.51%, reflecting the increasing use of nutrition as part of companion-animal health management.

That shift does not displace the large-volume base. Dry, conventional, animal-derived, and commercial-manufacturing segments will continue to anchor total demand because they provide scale and cost efficiency. The strategic opportunity lies in attaching specialty content to those large platforms, rather than treating premium and conventional demand as separate markets. Suppliers that can demonstrate performance at practical inclusion rates will be better positioned than those relying on broad sustainability or health narratives alone.

Pet Food Ingredients Market Regional Analysis

North America

North America is projected to expand from USD 11.901 billion in 2022 to USD 23.226 billion by 2035. The United States is the region's core demand center, supported by USD 51.7 billion in retail pet food and treat sales in 2024 and a large industrial production base . Mature ownership levels mean that ingredient growth depends increasingly on premium protein sourcing, functional reformulation, fresh formats, and traceability rather than basic category penetration.

The region is also a major regulatory reference point for novel inputs. FDA's animal-food consultation framework and AAFCO's newer scientific-review pathway create a more defined route for ingredient developers, although companies must still manage data requirements and label considerations ^{[6]U.S. Food and Drug Administration - Evaluation of FDA Pre-Market Animal Food Programs and Plan for Consultations, updated January 6, 2025 - fda.gov}, . For suppliers, regulatory readiness is increasingly part of the commercial offer, particularly in insect proteins, microbiome-support ingredients, and specialized premixes.

Europe

Europe is forecast to grow from USD 9.006 billion in 2022 to USD 17.420 billion by 2035. The region's ingredient market is shaped by premium food demand, demanding safety standards, and an expanding regulatory basis for selected natural and novel inputs. The authorization of liquid rosemary extract for cats and dogs provides a specific example of regulatory support for natural preservation systems .

European suppliers also face pronounced agricultural and sourcing sensitivity. Pulse and oilseed availability, sustainability requirements, and traceability expectations influence formulation decisions more directly than in less-regulated markets. The consequence is an advantage for suppliers that can offer robust documentation, diversified sourcing, and technically reliable alternatives when crops or imports become constrained.

Asia Pacific

Asia Pacific is projected to rise from USD 7.720 billion in 2022 to USD 16.129 billion by 2035, making it the largest contributor to incremental demand among the three largest regions. China, India, Japan, Australia, and South Korea represent materially different opportunity profiles: Japan and South Korea favor premium, age-specific, and fresh concepts, whereas India and other developing markets offer earlier-stage commercial feeding adoption.

The region rewards localization. Ingredients, formats, and claims must align with local price points, pet preferences, distribution infrastructure, and regulatory requirements. Suppliers that can apply global technical platforms while adapting protein sources, premix design, and pack-format economics will be better placed to capture regional growth than firms relying on imported premium products alone.

Latin America

Latin America is expected to increase from USD 2.252 billion in 2022 to USD 4.839 billion by 2035. Brazil is the key regional market, supported by a large domestic pet sector and growing commercial food demand. U.S. dog and cat food exports to Latin America increased 11% in 2024, indicating continued market integration and demand for commercially formulated products .

The region's 6.06% CAGR reflects a combination of commercial feeding expansion and premiumization from a lower base than North America or Europe. However, inflation, currency exposure, and local purchasing-power constraints can make formulation economics volatile. Suppliers need portfolios that accommodate both accessible mainstream formulas and higher-margin functional or premium products.

Middle East & Africa

The Middle East & Africa is forecast to expand from USD 1.287 billion in 2022 to USD 2.903 billion by 2035, the fastest rate among the major regions. Growth is supported by urbanization, expanding pet-keeping culture, and a still-developing commercial pet food base. GCC markets are particularly dependent on imported ingredients and finished products, which raises the importance of supply continuity, freight economics, and regional compliance.

Animal-derived ingredient sourcing can be especially complex because safety, origin, and halal requirements must be managed together. This creates an opportunity for suppliers that can provide traceability and documentation alongside dependable logistics. The region's growth is attractive, but it will reward staged market development rather than an undifferentiated export model.

The strongest suppliers will separate what must be standardized from what must be localized. Safety systems, technical documentation, ingredient quality, and formulation science can be scaled globally. Protein choice, price architecture, regulatory support, and supply-chain design must be adapted to regional purchasing power and operating conditions. This distinction is central to converting high-growth regional forecasts into profitable ingredient sales.

Pet Food Ingredients Market Share & Competitive Landscape

Competition spans diversified agricultural processors, specialty nutrition companies, premix suppliers, palatability specialists, renderers, and distribution-led solution providers. Portfolio breadth matters, but the more durable competitive advantages are regulatory capability, application support, traceable sourcing, supply reliability, and the ability to demonstrate finished-product performance.

DSM-Firmenich supplies vitamins, carotenoids, omega-3 ingredients, enzymes, cultures, colorants, and premix systems for pet nutrition. Its Taste, Texture & Health division reported EUR 3.146 billion in 2025 sales, and the company opened its automated pet-only NextGen Tonganoxie premix facility in Kansas in October 2025 ^{[7]DSM-Firmenich - Integrated Annual Report 2025: Taste, Texture & Health, 2025 - annualreport.dsm-firmenich.com}, .

Cargill, Incorporated participates through animal nutrition, proteins, fats, grains, oilseeds, and premix capabilities. Its acquisition of two U.S. feed mills from Compana Pet Brands strengthened production and distribution capacity, while its 2025 binding offer for Brazil's Mig-Plus signals further investment in Latin American animal-nutrition capability ^{[8]Cargill - Cargill Acquires Two U.S. Feed Mills, Strengthens Production and Distribution Capabilities, September 5, 2024 - cargill.com}, .

Archer-Daniels-Midland Company (ADM) combines agricultural processing with functional ingredients, biotics, specialty proteins, and formulation support. ADM's consumer research and its distribution relationship for Innovafeed black soldier fly larvae protein and oil position the company at the intersection of functional nutrition and alternative-protein commercialization , .

Evonik Industries AG is a major supplier of feed-grade amino acids, notably MetAMINO® DL-methionine. Its August 2024 Singapore expansion added 40,000 metric tons of annual MetAMINO® capacity, strengthening the company's supply position for amino acid balancing and specialty nutrition applications .

BASF SE supplies vitamins, carotenoids, organic acids, and enzymes for companion-animal applications. In October 2025, BASF launched Lutavit® A/D3 1000/200 NXT, a combined microencapsulated vitamin A and D3 product designed to simplify premix formulation .

Adisseo France SAS supplies methionine and vitamin solutions, including liquid methionine systems relevant to wet and liquid premix applications. Its 2026 Microvit® Nutrition Guide updated vitamin recommendation resources across companion-animal and other species applications .

Kemin Industries, Inc. serves pet food through its Nutrisurance business, including antioxidant, palatability, and digestive-health solutions. The company's EU authorization for liquid rosemary extract and its 2025 acquisition of Bactana expand its position in natural preservation and intestinal-health technologies , .

Symrise AG competes in pet palatability and pet nutrition, with capabilities in spray-dried palatants, liquid coatings, and protein-based ingredients. Symrise reported double-digit growth in parts of its pet-food business in Latin America and Asia Pacific, including China, during 2024 .

Darling Ingredients Inc. supplies rendered animal proteins, fats, collagen, gelatin, plasma, and other co-product streams. Its proposed Nextida™ joint venture with Tessenderlo Group would combine Rousselot and PB Leiner collagen operations, creating a larger platform for collagen-based nutrition applications .

Ingredion, Inc. participates through plant-based protein, starch, fiber, and texture solutions, including pulse and pea-protein inputs relevant to plant-forward and functional pet food formulations.

Prinova provides specialty ingredient distribution, sourcing, and custom-blending capabilities for manufacturers seeking consolidated premix and functional-ingredient procurement.

Novus International participates in animal nutrition through chelated trace minerals, amino acid products, enzyme technology, and technical nutrition support.

Recent Industry Developments

DSM-Firmenich opened the NextGen Tonganoxie pet premix facility in Kansas on October 20, 2025. The dedicated facility uses automated micro-ingredient additions and traceable batch assembly to serve pet food customers in the United States, Canada, and Mexico .

BASF launched Lutavit® A/D3 1000/200 NXT on October 15, 2025. The combined vitamin A and D3 formulation is produced in Ludwigshafen and is intended to simplify premix assembly while providing a consistent vitamin ratio .

Kemin Industries acquired Bactana in May 2025. The acquisition added intestinal-health and fermentation technology to Kemin's animal nutrition and pet food capabilities .

Darling Ingredients and Tessenderlo Group announced a proposed Nextida™ joint venture on May 12, 2025. The proposed business would combine collagen and gelatin operations from Rousselot and PB Leiner, subject to regulatory approvals .

Cargill announced a binding offer to acquire Mig-Plus in Brazil in 2025. Mig-Plus supplies premixes, feed concentrates, and complete-feed solutions, extending Cargill's animal-nutrition footprint in Brazil .

FDA and AAFCO introduced new U.S. ingredient-review mechanisms between October 2024 and January 2025. FDA finalized guidance covering enforcement policy and the Animal Food Ingredient Consultation process, while AAFCO introduced a new scientific review pathway administered with Kansas State University , .

The European Commission authorized liquid rosemary extract as an antioxidant additive for cats and dogs in April 2024. The authorization added a natural preservation option for European pet food formulators .

The European Union authorized UV-treated yellow mealworm powder as a novel food in January 2025. The authorization provides a further regulatory reference point for insect-derived protein development in Europe .